Clinical significance of homologous recombination deficiency score testing in endometrial Cancer.
CONCLUSIONS: High HRD score was associated with worse DFS in our patient cohort. These findings suggest that HRD score may have clinical utility in patients with advanced or recurrent endometrial cancer.
PMID: 33563487 [PubMed - as supplied by publisher]
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Siedel JH, Ring KL, Hu W, Dood RL, Wang Y, Baggerly K, Darcy KM, Conrads TP, Gallagher S, Tshiaba P, Neff C, Timms KM, Mangala S, Westin SN, Broaddus R, Lopez-Berestein G, Lu KH, Coleman RL, Maxwell GL, Sood AK Tags: Gynecol Oncol Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Endometrial Cancer | Science